Caring for HIV-Positive and Aging Patients With Associated Facial Lipoatrophy

Plastic Surgical Nursing

Volumn 26, Issue 1, 2006, Pages 17-23

  Esch, Pamela ^a  

^a Spokane Dermatology Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; COLLAGEN; HYALURONIC ACID; HYDROXYAPATITE; LACTIC ACID; POLITEF; POLYLACTIC ACID; POLYMER;

BODY IMAGE; CUTANEOUS PARAMETERS; DRUG EFFECT; ESTHETIC SURGERY; FACE; HIV ASSOCIATED LIPODYSTROPHY; HOSPITALIZATION; HUMAN; INFORMED CONSENT; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; PATHOLOGY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

BIOCOMPATIBLE MATERIALS; BODY IMAGE; COLLAGEN; COSMETIC TECHNIQUES; DURAPATITE; FACE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYALURONIC ACID; INFORMED CONSENT; LACTIC ACID; NURSE'S ROLE; NURSING ASSESSMENT; PATIENT EDUCATION; POLYMERS; POLYTETRAFLUOROETHYLENE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SKIN AGING;

EID: 33646839477     PISSN: 07415206     EISSN: 15501841     Source Type: Journal    
DOI: 10.1097/00006527-200601000-00006     Document Type: Article

References (53)

1. Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M. P., Nasti, G., Ridolfo, A. L., Mazzotta, F., Wu, A. W., d'Arminio Monforte, A., & Galli, M. (2002). Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S140-S144.
2. Benedetto, A., & Lewis, A. (2003). Injecting 1000 centistoke liquid silicone with ease and precision. Dermatologic Surgery, 29(3), 211-214.
3. Bergeret-Galley, C. (2004). Comparison of resorbable soft tissue fillers. Aesthetic Surgery Journal, 24, 33-43.
4. Bes, G. (2003). Efficacite du Juvederm 30: un an de suivi. Realites Therap Dermat Venerol, 127, 45-49.
5. Boss, W. K., Jr, Usal, H., Fodor, P. B., & Chernoff, G. (2000). Autologous cultured fibroblasts: A protein repair system. Annals of Plastic Surgery, 44, 536-542.
6. Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998). A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 12(7), F51-F58.
7. Carr, A., & Cooper, D. A. (2000). Adverse effects of antiretroviral therapy. Lancet, 356(9239), 1423-1430.
8. Cooper, D. (1998). Immunological effects of antiretroviral therapy. Antiviral Therapy, 3(Suppl 4), 19-23.
9. Cooperman, L. S., Mackinnon, V., Bechler, G., & Pharriss, B. B. (1985). Injectable collagen: A six-year clinical investigation. Aesthetic Plastic Surgery, 9(2), 145-151.
10. Chiesi, A., Mocroft, A., Dally, L. G., Miller, V., Katlama, C., Ledergerber, B., Pedersen, C., Phillips, A. N., Arcieri, R., & Lundgren, J. D. (1999). Regional survival differences across Europe in HIV-positive people: The EuroSIDA study. AIDS, 13(16), 2281-2288.
11. Collins, E., Wagner, C., & Walmsley, S. (2000). Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader, 10(9), 546-550.
12. Conrad, K., & Reifen, E. (1992). Gore-Tex implant as tissue filler in cheek-lip groove rejuvenation. Journal of Otolaryngology, 21(3), 218-222.
13. Deeks, S. (2000). Determinants of virological response to antiretroviral therapy: implications for long-term strategies. Clinical Infectious Diseases, 30(Suppl 2), S177-S184.
14. Donofrio, L. M. (2000). Fat distribution: a morphologic study of the aging face. Dermatologic Surgery, 26(12), 1107-1112.
15. Dukers, N. H., Stolte, I. G., Albrecht, N., Coutinho, R. A., & de Wit, J. B. (2001). The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. AIDS, 15(6), 812-813.
16. Duran, S., Saves, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P., Salmon, D., Moatti, J. P., & Leport, C. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS, 15(18), 2441-2444.
17. Gallant, J. (2000). Strategies for long-term success in the treatment of HIV infection. Journal of the American Medical Association, 283(10), 1329-1334.
18. Gogolewski, S., Jovanovic, M., Perren, S. M., Dillon, J. G., & Hughes, M. K. (1993). Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly (3-hydroxybutyrate) (PHB), and poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). Journal of Biomedical Material Research, 27(9), 1135-1148.
19. Golub, E. T., Astemborski, J. A., Hoover, D. R., Anthony, J. C., Vlahov, D., & Strathdee, S. A. (2003). Psychological distress and progression to AIDS in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes, 32(4), 429-434.
20. Gonzalez-Ulloa, M., Simonin, F., & Flores, E. (1971). The anatomy of the aging face. In J. T. Hueston (Ed.), Transactions of the fifth international congress of plastic and reconstructive surgery. London: Butterworth and Co Ltd, 1059-1066.
21. Grossbart, T. A., & Sarwer, D. B. (1999). Cosmetic surgery: Surgical tools-psychosocial goals. Seminars in Cutaneous Medicine and Surgery, 18(2), 101-111.
22. Hanke, C. (2002). A new ePTFE soft tissue implant for natural-looking augmentation of lips and wrinkles. Dermatologic Surgery, 28(10), 901-908.
23. Holmes, W., & Shea, J. (1998). A new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability and validity. Medical Care, 36, 138-154.
24. Kligman, A. M. (1989). Psychological aspects of skin disorders in the elderly. Cutis, 43(5), 498-501.
25. Kronenthal, R. L. (1975). Biodegradable polymers in medicine. In R. L. Kronenthal, Z. Oser, & E. Martin (Eds.), Polymer science and technology. New York: Plenum Press, 119-137.
26. Kulkarni, R. K., Moore, E. G., Hegyeli, A. F., & Leonard, F. (1971). Biodegradable poly(lactic acid) polymers. Journal of Biomedical Material Research, 5(3), 169-181.
27. Larsen, N. E., Pollak, C. T., Reiner, K., Leshchiner, E., & Balazs, E.A. (1993). Hylan gel biomaterial: Dermal and immunologic compatibility. Journal of Biomedical Material Research, 27(9), 1129-1134.
28. Lassus, C. (1991). Expanded PTFE in the treatment of facial wrinkles. Aesthetic Plastic Surgery, 15(2), 167-174.
29. Lenert, L. A., Feddersen, M., Sturley, A., & Lee, D. (2002). Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. American Journal of Medicine, 113(3), 229-232.
30. Lubeck, D., & Fires, J. (1992). Changes in quality of life among persons with HIV infection. Quality of Life Research, 1, 397-413.
31. Mayer, R., Lightfoot, M., & Jung, I. (2001). Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology, 57(3), 434-438.
32. Mole, B. (1992). The use of Gore-Tex implants in aesthetic surgery of the face. Plastic Reconstructive Surgery, 90(2), 200-206.
33. Moyle, G. J., Lysakova, L., Brown, S., Sibtain, N., Healy, J., Priest, C., Mandalia, S., & Barton, S. E. (2004). A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Medicine, 5(2), 82-87.
34. Nakamura, S., Ninomiya, S., Takatori, Y., Morimoto, S., Kusaba, I., & Kurokawa, T. (1993). Polylactide screws in acetabular osteotomy: 28 dysplastic hips followed for 1 year. Acta Orthopaedica Scandinavica, 64(3), 301-302.
35. Narins, R. S., Brandt, F., Leyden, J., Lorenc, Z. P., Rubin, M., & Smith, S. (2003). A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatologic Surgery, 29(6), 588-595.
36. Oette, M., Juretzko, P., Kroidl, A., Sagir, A., Wettstein, M., Siegrist, J., & Haussinger, D. (2002). Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients. AIDS Patient Care and STDS, 16(9), 413-417.
37. Onesti, M. G., Renzi, L. F., Paoletti, F., & Scuderi, N. (2004). Use of polylactic acid in face lipodystrophy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART). Acta Chirurgiae Plasticae, 46(1), 12-15.
38. Palella, F. J., Jr, Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. New England Journal of Medicine, 338(13), 853-860.
39. Pettit, D. K., Lawter, J. R., Huang, W. J., Pankey, S. C., Nightlinger, N. S., Lynch, D. H., Schuh, J. A., Morrissey, P. J., & Gombotz, W. R. (1997). Characterization of poly(glyco ide-co-D, L-lactide)/poly(D, L-lactide) microspheres for controlled release of GM-CSF. Pharmaceutical Research, 14(10), 1422-1430.
40. Power, R., Tate, H., McGill, S., & Taylor, C. (2003). A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections, 79(2), 137-141.
41. Rees, T., & Ashley, F. (1966). Treatment of facial atrophy with liquid silicone. American Journal of Surgery, 111, 531-535.
42. Rees, T., Ashley, F., & Delgado, J. (1972). Silicone fluid injections for facial atrophy. Plastic Reconstructive Surgery, 52, 118-127.
43. Sclafani, A., Romo, T., & Jacono, A. (2002). Rejuvenation of the aging lip with an injectable acellular dermal graft (Cymetra). Archives of Facial Plastic Surgery, 4(4), 252-257.
44. Sclafani, A., Romo, T., & Parker, A. (2002). Homologous collagen dispersion (dermalogen) as a dermal filler: persistence and histology compared with bovine collagen. Annals of Plastic Surgery, 49(2), 181-188.
45. Sklar, J., & White, S. (2004). Radiance FN: a new soft tissue filler. Dermatologic Surgery, 30(5), 764-768.
46. Smith, K., Avis, N., Mayer, K., & Swislow, L. (1997). Use of the MQoL-HIV with asymptomatic HIV-positive patients. Quality of Life Research, 6(6), 555-560.
47. Spenlehauer, G., Veillard, M., & Benoit, J. P. (1986). Formation and characterization of cisplatin loaded poly(d, l-lactide) microspheres for chemoembolization. Journal of Pharmaceutical Sciences, 75(8), 750-755.
48. Tzikas, T. (2004). Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Archives of Facial Plastic Surgery, 6(4), 234-239.
49. Valantin, M. A., Aubron-Olivier, C., Ghosn, J., Laglenne, E., Pauchard, M., Schoen, H., Bousquet, R., Katz, P., Costagliola, D., & Katlama, C. (2003). Polylactic acid implants (New-Fill)(R) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS, 17(17), 2471-2477.
50. Vleggaar, D., & Bauer, U. (2004). Facial enhancement and the European experience with poly-L-lactic acid. Journal of Drugs in Dermatology, 3(5), 526-530.
51. Wall, S. J., Adamson, P. A., Bailey, D., & van Nostrand, A. W. (2003). Patient satisfaction with expanded polytetrafluoroethylene (Softform) implants to the perioral region. Archives of Facial Plastic Surgery, 5(4), 320-324.
52. Woerle, B., Hanke, C. W., & Sattler, G. (2004). Poly-L-lactic acid: A temporary filler for soft tissue augmentation. Journal of Drugs in Dermatology, 3(4), 385-389.
53. Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr, Brysk, L. T., Hardy, W. D., Bozzette, S. A., Spector, S. A., & Richman, D. D. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Medical Care, 29(8), 786-798.